Browse Category

Investing News 31 October 2025 - 1 November 2025

AMTD Digital (HKD) – From Meme-Stock Mania to 2025 Revival: Shocking Rally, Red Flags, and What’s Next

AMTD Digital (HKD) Stock Rockets 208% on 1,086% Revenue Blast – Bubble or Bargain?

Recent News & Stock Surge In late October 2025, AMTD Digital stunned investors with a blockbuster earnings report. On Oct 31, the company announced H1 2025 revenue of $73.2M (up 1,085.9% YoY), driven by its October 2024 acquisition of TGE (bringing in L’Officiel and Art Newspaper) and growth in hospitality services streetinsider.com investing.com. Management highlighted $10.0M in media/marketing revenue (vs $4.4M prior) and $13.6M from hotels/VIP services (172% growth) streetinsider.com. Despite the revenue surge, a large portion came from fair-value gains ($47.9M on investment assets) streetinsider.com. Oct 31 Market Reaction: Traders piled in. HKD jumped from ~$1.69 pre-market to above
FuelCell Energy (FCEL) Stock Hits Peak Amid AI Hype – Is the Rally Sustainable?

FuelCell Energy (FCEL) Stock Hits Peak Amid AI Hype – Is the Rally Sustainable?

Stock Performance & Technical Overview FCEL’s chart has been a roller-coaster in October. The stock soared from ~$4 in August to trade above $11 by mid-October ts2.tech, reflecting the wave of excitement around AI and hydrogen. On Oct. 14, FCEL hit about $11.43 (a multi-month high) ts2.tech. However, profit-taking led to a sell-off: by Oct. 16 it was near $9.30, and it drifted down to $7.73 by the Oct. 30 close ts2.tech. Trading volume was well above normal during these swings, underlining speculative interest. On Oct. 31 the stock bounced 15.8% to close at $8.95 marketbeat.com. (MarketBeat notes FCEL’s 5-day
QuantumScape (QS) Stock Rockets on Solid-State Battery Breakthrough – Analysts Split on Future

QuantumScape (QS) Stock Rockets 180% Amid Solid-State Battery Breakthroughs – What Analysts Are Saying

Key Facts (as of Oct 31, 2025): QuantumScape’s shares trade around the mid $17 range ts2.tech – up roughly 170–180% year-to-date from near $3–$4 in January ts2.tech markets.financialcontent.com. The company, still pre-revenue, reported Q3 2025 EPS of –$0.18 (net loss ~$105.8M) – slightly beating the –$0.20 estimate s29.q4cdn.com – and posted $12.8M in “customer billings” (a new metric for invoice activity) investing.com s29.q4cdn.com. QS ended Q3 with about $1.0 billion in cash and equivalents, extending its cash runway into 2030 s29.q4cdn.com. In late Oct QS announced it began shipping “B1” prototype samples of its QSE‑5 solid‑state cells (built with its
Brighthouse Financial (BHF) Stock Soars on Takeover Buzz – Price Jump, Earnings Outlook & Expert Analysis

Brighthouse Financial (BHF) Stock Soars on Takeover Buzz – Price Jump, Earnings Outlook & Expert Analysis

Short-Term and Long-Term Outlook Deal or No Deal: In the short term, Brighthouse’s fate may hinge on the takeover negotiations. If Aquarian finalizes a buyout near $70/share, the stock could quickly gravitate toward that price (roughly 25% above where it traded post-rumor) and shareholders would lock in a substantial one-time gain investing.com. Market watchers note that private equity interest in life insurers is driven by the opportunity to earn higher returns on insurers’ investment portfolios reuters.com. Aquarian’s rumored ~$4 billion offer (at $70) underscores that strategic buyers see more value in Brighthouse than the public market does – a sentiment
Illumina Stock Surges on Genomics Breakthroughs – What’s Next for ILMN?

Illumina Stock Surges on Genomics Breakthroughs – What’s Next for ILMN?

Q3 2025 Earnings: Beat Expectations and Lifted Guidance Illumina’s latest quarterly report (Q3 FY2025) provided a much-needed spark for investors. The San Diego-based genomics giant reported $1.084 billion in revenue for Q3, slightly above Wall Street estimates (~$1.07B) and flat versus the same quarter last year investing.com. While flat growth might not sound impressive, it exceeded Illumina’s own guidance range, marking an improvement in a year where demand had been soft. Adjusted earnings were $1.34 per share, handily beating the ~$1.17 consensus investing.com. CEO Jacob Thaysen noted the team “delivered Q3 results that exceeded the high-end of our guidance… driven by
31 October 2025
Cloudflare (NET) Stock Soars to Record High on Earnings and AI Buzz – What’s Next for Investors?

Cloudflare (NET) Stock Soars to Record High on Earnings and AI Buzz – What’s Next for Investors?

Stock Performance and Recent Trends Cloudflare’s stock price has been on a tear in 2025, recently hitting an all-time high around $230 per share watcher.guru. After a rally into its Q3 earnings announcement, the stock closed October 30 at $222.94 (down ~1.9% that day after profit-taking) ts2.tech, then spiked in after-hours trading once results beat expectations ts2.tech. As of October 31, 2025, NET trades in the mid-$220s – roughly 95–100% higher than where it started the year ts2.tech. For context, the Nasdaq-100 is up only ~40% YTD, so Cloudflare has dramatically outpaced the broader market. Investors have rewarded the company
Robinhood’s Wild 2025 Ride: HOOD Stock Skyrockets 250% Amid Crypto Boom, New Gambits & Big Risks

Robinhood’s Wild 2025 Ride: HOOD Stock Skyrockets 250% Amid Crypto Boom, New Gambits & Big Risks

Overview of Robinhood Markets, Inc. Founded in 2013 with a mission to make investing accessible, Robinhood has grown into one of the most widely used retail trading platforms in the U.S. The app’s gamified, user-friendly interface – with instant account setup and free trades – brought a new generation into the stock market. By mid-2025, Robinhood reported 26.5 million funded accounts on its platform ts2.tech. For context, that user base rivals the largest traditional brokers: Charles Schwab, after its TD Ameritrade acquisition, has ~38 million active brokerage accounts pressroom.aboutschwab.com. Unlike those full-service brokers, Robinhood does not offer personalized financial advice,
DexCom Stock Plunge Raises Big Questions – Will This Diabetes Tech Leader Rebound?

DexCom Stock Plunge Raises Big Questions – Will This Diabetes Tech Leader Rebound?

Latest News: Earnings Beat Marred by Growth Jitters DexCom’s Q3 2025 earnings (reported Oct. 30) were better than expected, but the celebration was short-lived. The headline numbers were strong – $1.209 B revenue (+22% YoY) and $0.61 adjusted EPS – beating consensus on both investing.com. In fact, demand for DexCom’s G7 continuous glucose monitors (CGMs) drove 20% organic growth globally, with U.S. sales up 21% and international up 18% YoY investing.com. Off the back of this strength, management raised full-year 2025 guidance, now targeting ~$4.63 B revenue (~15% growth) investors.dexcom.com and improved operating margins around 20–21%. However, on the earnings call DexCom’s
Astera Labs Stock Skyrockets on AI Buzz and Photonics Deal – Can ALAB Keep Climbing?

Astera Labs Stock Skyrockets on AI Buzz and Photonics Deal – Can ALAB Keep Climbing?

Astera Labs Stock Price & Recent Movement (October 2025) Astera Labs’ stock has been on a roller coaster in recent weeks. After skyrocketing through mid-2025 on AI frenzy, ALAB shares peaked at an all-time high of $262.90 on September 18, 2025 ts2.tech. A broad tech sell-off and profit-taking then set in: by early October, Astera had pulled back to the mid-$190s ts2.tech. Volatility spiked mid-month – on October 14–15, the stock plunged from ~$200 to the low-$160s, a nearly 19% two-day drop ts2.tech. The immediate trigger was AMD’s October 14 announcement of a 50,000-GPU deal with Oracle, which stoked fears
Newell Brands Stock Crashes on Tariff Woes – Inside NWL’s Plunge and Turnaround Struggles

Newell Brands Stock Crashes on Tariff Woes – Inside NWL’s Plunge and Turnaround Struggles

In-Depth Report Stock Price Plunge and Recent Performance Newell Brands’ stock cratered in late October 2025, culminating in a one-day collapse on October 31 after its earnings release. The shares fell from about $4.72 to around $3.25 in a single session, a drop of roughly 32% tokenist.com. This rout left the stock at its lowest price on record tokenist.com, an astonishing fall for a company that five years ago traded above $20 per share. The selloff on Oct. 31 was precipitated by disappointing quarterly results and a hefty cut to the company’s outlook (more on that below). It capped off
31 October 2025
QuantumScape (QS) Stock Soars 200% on EV Battery Breakthroughs – What’s Next for This High-Voltage Bet?

QuantumScape (QS) Stock Soars 200% on EV Battery Breakthroughs – What’s Next for This High-Voltage Bet?

Stock Surge and Recent Performance 📈 QuantumScape’s stock (NYSE: QS) has been on a tear in 2025, delivering one of the market’s most dramatic rallies. After starting the year in the low-single-digits, QS shares went nearly 5× higher, propelled by optimism around its solid-state battery technology. By mid-October, the stock had gained about 170–180% year-to-date, vastly outpacing the broader indices ts2.tech. The rally accelerated in late September and early October on a string of positive announcements, with the stock hitting an intraday peak around $16.49 by October 3 ts2.tech. It even flirted with the $19 level shortly thereafter, marking a
ONDS Stock’s Wild Ride: Drone Darling or Bubble in the Making?

ONDS Stock’s Wild Ride: Drone Darling or Bubble in the Making?

Current Stock Price & Recent Performance At $6.29 per share (Oct 31 opening) marketbeat.com, ONDS is well off its early-October highs. The stock peaked at $10+ in the first week of October, briefly touching a 52-week high of $11.70 marketbeat.com after a flurry of good news. Since then it has pulled back ~40% on profit-taking and broader market jitters stockinvest.us. Over just the last three trading days, ONDS sank -6.8%, -0.6%, and -9.8% respectively, reflecting volatile swings as traders lock in gains futunn.com aaii.com. Despite this recent slump, Ondas shares remain up astronomically over longer time frames. The stock started
31 October 2025
1 9 10 11 12 13 65
Go toTop